Source: FinanzNachrichten

DBV Technologies: DBV Technologies S.A.: DBV Technologies to Participate in the Citizens JMP Life Sciences Conference

Châtillon, France, May 5, 2025 DBV Technologies to Participate in the Citizens JMP Life Sciences Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clin...

Read full article »
DBV Technologies's Competitors | DBV Technologies's News | DBV Technologies's Financials
Stay up-to-date with the latest news on DBV Technologies
Annual Revenue
$100K-5.0M
Employees
100-250
Daniel Tasse's photo - CEO of DBV Technologies

CEO

Daniel Tasse

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on DBV Technologies